161 related articles for article (PubMed ID: 25112687)
1. Identification of new novel scaffold for Aurora A inhibition by pharmacophore modeling and virtual screening.
Chavan SR; Dash RC; Alam MS; Hirwani RR
Mol Divers; 2014 Nov; 18(4):853-63. PubMed ID: 25112687
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potential Aurora-A kinase inhibitors by 3D QSAR pharmacophore modeling, virtual screening, docking, and MD simulation studies.
Swamy P M G; Abbas N; Dhiwar PS; Singh E; Ghara A; Das A
J Biomol Struct Dyn; 2023 Jan; 41(1):125-146. PubMed ID: 34809538
[TBL] [Abstract][Full Text] [Related]
3. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening.
Chaudhari P; Bari S
Mol Divers; 2016 Feb; 20(1):41-53. PubMed ID: 26416560
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the structural requirements of Aurora Kinase B inhibitors by a combined QSAR, modelling and molecular simulation approach.
Ashraf S; Ranaghan KE; Woods CJ; Mulholland AJ; Ul-Haq Z
Sci Rep; 2021 Sep; 11(1):18707. PubMed ID: 34548506
[TBL] [Abstract][Full Text] [Related]
5. Identification of Novel Aurora Kinase A (AURKA) Inhibitors via Hierarchical Ligand-Based Virtual Screening.
Kong Y; Bender A; Yan A
J Chem Inf Model; 2018 Jan; 58(1):36-47. PubMed ID: 29202231
[TBL] [Abstract][Full Text] [Related]
6. Multicomplex-based pharmacophore-guided 3D-QSAR studies of N-substituted 2'-(aminoaryl)benzothiazoles as Aurora-A inhibitors.
He G; Qiu M; Li R; Ouyang L; Wu F; Song X; Cheng L; Xiang M; Yu L
Chem Biol Drug Des; 2012 Jun; 79(6):960-71. PubMed ID: 22381081
[TBL] [Abstract][Full Text] [Related]
7. Combined 3D-QSAR modeling and molecular docking studies on pyrrole-indolin-2-ones as Aurora A kinase inhibitors.
Ai Y; Wang ST; Sun PH; Song FJ
Int J Mol Sci; 2011; 12(3):1605-24. PubMed ID: 21673910
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR and molecular docking studies on derivatives of MK-0457, GSK1070916 and SNS-314 as inhibitors against Aurora B kinase.
Zhang B; Li Y; Zhang H; Ai C
Int J Mol Sci; 2010 Nov; 11(11):4326-47. PubMed ID: 21151441
[TBL] [Abstract][Full Text] [Related]
10. Docking and three-dimensional quantitative structure-activity relationship analyses of imidazole and thiazolidine derivatives as Aurora A kinase inhibitors.
Im C
Arch Pharm Res; 2016 Dec; 39(12):1635-1643. PubMed ID: 27909956
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity.
Oluić J; Nikolic K; Vucicevic J; Gagic Z; Filipic S; Agbaba D
Comb Chem High Throughput Screen; 2017 Aug; 20(4):292-303. PubMed ID: 28460621
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer Agents.
Patel P; Singh A; Patel VK; Jain DK; Veerasamy R; Rajak H
Comb Chem High Throughput Screen; 2016; 19(9):735-751. PubMed ID: 27487787
[TBL] [Abstract][Full Text] [Related]
13. Probing the structural requirements of A-type Aurora kinase inhibitors using 3D-QSAR and molecular docking analysis.
Zhang HX; Li Y; Wang X; Wang YH
J Mol Model; 2012 Mar; 18(3):1107-22. PubMed ID: 21670994
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening.
Kilchmann F; Marcaida MJ; Kotak S; Schick T; Boss SD; Awale M; Gönczy P; Reymond JL
J Med Chem; 2016 Aug; 59(15):7188-211. PubMed ID: 27391133
[TBL] [Abstract][Full Text] [Related]
15. QSAR studies on imidazopyrazine derivatives as Aurora A kinase inhibitors.
Leng Y; Lu T; Yuan HL; Liu HC; Lu S; Zhang WW; Jiang YL; Chen YD
SAR QSAR Environ Res; 2012 Oct; 23(7-8):705-30. PubMed ID: 22971111
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase B.
Masand VH; Al-Hussain SA; Rathore MM; Thakur SD; Akasapu S; Samad A; Al-Mutairi AA; Zaki MEA
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498857
[TBL] [Abstract][Full Text] [Related]
17. A Combined Pharmacophore Modeling, 3D QSAR and Virtual Screening Studies on Imidazopyridines as B-Raf Inhibitors.
Xie H; Chen L; Zhang J; Xie X; Qiu K; Fu J
Int J Mol Sci; 2015 May; 16(6):12307-23. PubMed ID: 26035757
[TBL] [Abstract][Full Text] [Related]
18. Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3).
Kaur M; Silakari O
J Biomol Struct Dyn; 2017 Nov; 35(14):3043-3060. PubMed ID: 27678281
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking.
Lee YH; Yi GS
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336555
[TBL] [Abstract][Full Text] [Related]
20. Atom Based 3D-QSAR, Molecular Docking and Density Functional Theory Approaches to Identify Novel JNK-1 Inhibitor.
Shylaja R; Kavitha R; Meganathan C
Comb Chem High Throughput Screen; 2016; 19(9):771-797. PubMed ID: 27585829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]